Guinta v. Merck & Co., Inc. | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Guinta v. Merck & Co., Inc.

Sort by

Viewing results 1‒25 of 1222

Coronavirus treatment
Merck Covid antiviral pill did not cut hospitalisation risk, study finds
...Merck’s Covid-19 antiviral pill failed to show it can lower the risks of hospitalisation and death among adults at higher risk from the disease, according to the results of a pivotal clinical trial in the...
October 6, 2022
Menswear
V-necks are back
...At the mid-level, a cashmere style in a muted shade from Sheep Inc, John Smedley or — my favourite — Begg x Co will quickly become a staple of your wardrobe....
April 8, 2024
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
Merck & Co Inc
Merck to open £1bn London research centre with plea for government support of industry
...Dean Li, president of Merck’s research laboratories, praised the UK’s scientific talent and expertise, hoping that the investment in King’s Cross will help researchers at MSD, known as Merck in the US, work...
October 15, 2023
Coronavirus treatment
Covid antivirals lose spark as regulatory scrutiny increases
...A person familiar with the process said Merck “understood there was no hope . . . [Lagevrio] is a bit burnt”....
October 9, 2023
The Week Ahead
Opening arguments begin in Trump trial
...and Serbia 200th day of the Hamas-Israel conflict after Hamas launched an attack on Israel on October 7 last year UK: 100th anniversary of both the first radio broadcast by a British monarch, George V...
April 21, 2024
Coronavirus treatment
Merck struggles to win European approval for Covid antiviral pill
...But future demand would suffer unless Merck was able to provide better clinical data....
February 16, 2022
FT Live
Global Pharma and Biotech Summit
Driving life sciences innovation in a disrupted world
Tuesday, 5 NovemberIn-Person & Online Conference
US politics & policy
US targets 10 drugs for pricing negotiations in crackdown on costs
...The new rules give the federal government the power to negotiate lower prices for some of the most expensive prescription drugs produced by Pfizer, Merck and other pharma companies purchased by Medicare,...
August 29, 2023
Coronavirus treatment
Covid antiviral drug linked to ‘transmissible’ mutations, research finds
...Molnupiravir, marketed by Merck and co-developed with US biotech group Ridgeback Biotherapeutics, works by inducing small mutations in the virus itself....
September 25, 2023
Merck & Co Inc
Merck accuses US of ‘extortion’ in lawsuit against drug price controls
...He said Merck’s claim that the reforms were an “extortion” was accurate....
June 6, 2023
InterviewBlackRock Inc
How Adebayo Ogunlesi’s contrarian bet led to $12.5bn BlackRock tie-up
...When Ken Frazier, another law school friend, was CEO of Merck and facing criticism for refusing to cut research budgets, Ogunlesi reassured him he was doing the right thing....
January 14, 2024
LexMerck & Co Inc
Merck/Prometheus: Big Pharma must swallow bigger premiums Premium content
...Merck is either optimistic or desperate if it is willing to pay $5bn more than Prometheus’ valuation three days ago. But it has the funds....
April 17, 2023
Mergers & Acquisitions
Merck buys Prometheus Biosciences for almost $11bn
...Under the terms of the transaction Merck is acquiring Prometheus through a subsidiary....
April 16, 2023
Coronavirus treatment
Merck antiviral trial shows promising impact on Covid recovery time
...“We are encouraged by these findings from Panoramic,” said Merck, which is known as MSD outside North America....
December 22, 2022
Pharmaceuticals sector
Big Pharma fights patent disclosure demand from investors
...“When appropriate, Merck seek to protect its additional innovation,” he added. Merck said it continued to point to late 2028 as the most likely timeframe for biosimilar entry into the market....
February 26, 2023
Drugs research
Moderna’s mRNA cancer vaccine shows promise in early trial
...Weber is a paid consultant for Merck and Moderna....
December 13, 2022
FT Live
Due Diligence Live
Where leaders in investment and finance meet
Tuesday, 8 OctoberLondon, UK
LexDrugs research
Medicines: triumph of science in 2022 is worth celebrating Premium content
...Merck’s Keytruda now tackles 18 tumour types and is set to be the world’s top-selling medicine next year, according to Evaluate Vantage....
December 23, 2022
Pharmaceuticals sector
Merck defends tax approach against senator’s claims of avoidance
...Chief financial officer Caroline Litchfield said the company operates with the highest “ethics and integrity in absolutely everything we do” and is continuing to co-operate with the Senate finance committee...
August 7, 2022
LexMerck & Co Inc
Merck/SeaGen: regulatory hurdles will be tough to clear Premium content
...SeaGen lacks a permanent chief executive after co-founder Clay Siegall stepped down in May, so Merck may be tempted to push ahead....
July 8, 2022
Pharmaceuticals sector
Merck in talks over $40bn deal for cancer biotech SeaGen
...Merck & Co is in talks to buy the cancer biotechnology company SeaGen for about $40bn, according to two people familiar with the matter....
July 7, 2022
Pfizer Inc
Pfizer pins hopes on record pipeline to recover from post-Covid hangover
...“Pfizer is very good at selling but historically not renowned as having the R&D engine of a Merck or Lilly....
February 21, 2023
Eisai Co Ltd
Japan’s Eisai aims to silence critics over breakthrough Alzheimer’s drug
...Both Roche’s gantenerumab and lecanemab, co-developed by Eisai and Biogen, are monoclonal antibody treatments based on the hypothesis....
November 29, 2022
Covid-19 vaccines
France cancels order for Merck antiviral tablet on efficacy fears
...Merck said it had supply agreements with over 30 countries....
December 22, 2021
Coronavirus treatment
Merck takes aim at Pfizer’s Covid pill as concerns linger over its own drug
...This was sharply lower than the 50 per cent efficacy that Merck announced in October from a preliminary analysis of the data....
December 5, 2021
Coronavirus treatment
Merck says its Covid antiviral treatment less effective than first thought
...Molnupiravir, co-developed with Ridgeback Biotherapeutics and also known as Lagevrio, has been approved for use in the UK. European regulators are also reviewing it....
November 26, 2021
Coronavirus treatment
Merck’s Covid pill secures narrow backing from US regulatory panel
...Last week, Merck said the treatment was less effective than it had thought....
November 30, 2021

Previous pagePage 1 of 49Next page